Faber Logo Skip to main content

Our Clients

We have worked with over 2000 companies, investors and research institutions.

All clients, by client group

  • Alliance Foundation Trials, LLC
  • Bluefield Project to Cure FTD
  • Commonwealth Cancer Consortium (Break Through Cancer)
  • Cure GM1 Foundation
  • Foundation for Angelman Syndrome Therapeutics (FAST)
  • Global Alliance for TB Drug Development
  • The N=1 Collaborative, Inc.
  • Tufts University
Learn more about our work in this industry

  • ActNano, Inc.
  • Ambulomics, Inc.
  • Arcaea, LLC
  • Biobot Analytics, Inc.
  • CAMP4 Therapeutics, Inc.
  • Day Zero Diagnostics, Inc.
  • GelMEDIX, Inc.
  • HighRes Biosolutions, Inc.
  • Instylla, Inc.
  • JC Medical, Inc.
  • Palette Life Sciences AB
  • PolarSeal Tapes & Conversions Ltd.
  • Polypeptide Therapeutic Solutions US - Curapath
  • Proof Diagnostics Inc.
  • SAGA Dx, Inc.
  • Savran Technologies Inc.
  • Sirtex Technology Pty Ltd
  • Spectral Medical Inc.
  • Tides Medical, LLC
  • Vizgen, Inc.
Learn more about our work in this industry

  • Abata Therapeutics, Inc.
  • Abcentra LLC
  • Accent Therapeutics, Inc.
  • Actithera, Inc.
  • Adrenas Therapeutics, Inc.
  • Aerium Therapeutics, Inc.
  • Affini-T Therapeutics, Inc.
  • Affinia Therapeutics, Inc.
  • Akebia Therapeutics, Inc.
  • Aktis Oncology, Inc.
  • Aldeyra Therapeutics, Inc.
  • Aliada Therapeutics, Inc.
  • Allorion Therapeutics Inc.
  • Alltrna, Inc.
  • Allyx Therapeutics, Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Ananda Scientific, Inc.
  • Anebulo Pharmaceuticals, Inc.
  • Anokion US, Inc.
  • Anthos Therapeutics, Inc.
  • Antidote Therapeutics, Inc.
  • Apic Bio, Inc.
  • Arbor Biotechnologies, Inc.
  • Arcadia Science LLC
  • Artax Biopharma, Inc.
  • ARTBIO Inc.
  • AS2 Bio Inc.
  • AsclepiX Therapeutics, Inc.
  • Aspa Therapeutics, Inc.
  • Astria Therapeutics, Inc.
  • Atavistik Bio
  • Atomwise Inc.
  • aTyr Pharma, Inc.
  • Aura Biosciences, Inc.
  • Auron Therapeutics, Inc.
  • Auxolytic, Ltd.
  • AvenCell Therapeutics, Inc.
  • Axial Therapeutics, Inc.
  • Bicara Therapeutics Inc.
  • Bill & Melinda Gates Foundation and the Bill & Melinda Gates Medical Research Institute
  • BioSynapse, Inc.
  • Blue Oak Pharmaceuticals, Inc.
  • Carbon Biosciences, Inc.
  • Cardurion Pharmaceuticals, Inc.
  • Cedilla Therapeutics, Inc.
  • CG Pharmaceuticals, Inc.
  • Chordia Therapeutics, Inc.
  • Claris Biotherapeutics, Inc.
  • Cloverleaf Bio, Inc.
  • Cora Biosciences, Inc.
  • Corner Therapeutics, Inc.
  • Cyteir Therapeutics, Inc.
  • Deciphera Pharmaceuticals, LLC
  • Delphia Therapeutics, Inc.
  • DEM BioPharma, Inc.
  • Dianthus Therapeutics OpCo, Inc.
  • Dicerna Pharmaceuticals, Inc.
  • Diceros Therapeutics, Inc.
  • Disc Medicine, Inc.
  • Dispatch Biotherapeutics, Inc.
  • Domain Therapeutics USA, Inc.
  • Doppler Bio, Inc.
  • Eicosis LLC
  • Elevian, Inc.
  • Elicio Therapeutics, Inc.
  • Emerald Lake Safety LLC
  • Epalex Corporation
  • Epibiologics, Inc.
  • Ernest Pharmaceuticals, LLC
  • EvolveImmune Therapeutics, Inc.
  • Expansion Therapeutics, Inc.
  • Forma Therapeutics, Inc.
  • General Oncology, Inc.
  • Generate Biomedicines
  • GV.M1 Inc.
  • GV20 Therapeutics LLC
  • hC Bioscience, Inc.
  • Helix Nanotechnologies, Inc.
  • Hemab ApS
  • HilleVax, Inc
  • Hillstar Bio, Inc.
  • HotSpot Therapeutics, Inc.
  • HUTCHMED Limited
  • Hyku Biosciences, Inc.
  • IDBiologics, Inc.
  • IDEAYA Biosciences, Inc.
  • Ikena Oncology, Inc.
  • Immunocodex, Inc.
  • ImmunoGen, Inc.
  • InflaRx Pharmaceuticals, Inc.
  • Jumble Therapeutics, Inc.
  • Kanyos Bio, Inc.
  • Karuna Therapeutics, Inc.
  • Kelonia Therapeutics, Inc.
  • Korro Bio, Inc
  • KSQ Therapeutics, Inc.
  • Kymera Therapeutics, Inc.
  • Launchpad Therapeutics, Inc.
  • Linden Lake Labs
  • Lumen Bioscience, Inc.
  • Lyra Therapeutics, Inc.
  • Magnet Biomedicine, Inc.
  • Mahzi Therapeutics
  • Mariana Oncology
  • MarPam Pharma, LLC
  • MediBeacon Inc.
  • Merlin Therapeutics, Inc.
  • Mnemo Therapeutics SAS
  • Modal Therapeutics, Inc.
  • Molecular Templates, Inc.
  • Moment Bio, Inc.
  • Myeloid Therapeutics, Inc.
  • Neurogastrx, Inc.
  • NextPoint Therapeutics, Inc.
  • NextRNA Therapeutics, Inc.
  • Normunity AccelCo, Inc.
  • Normunity, Inc.
  • NorthSea Therapeutics, B.V.
  • Novo Nordisk A/S
  • Nurix Therapeutics, Inc.
  • Obsidian Therapeutics, Inc.
  • Okava Pharmaceuticals, Inc.
  • Olaris Inc.
  • Oligomerix, Inc.
  • Omega Therapeutics, Inc.
  • Oncorus, Inc.
  • OneCyte Biotechnologies, Inc.
  • ONK Therapeutics Limited
  • Onsero Therapeutics Inc
  • Orna Therapeutics, Inc.
  • Oviva Therapeutics, Inc.
  • PanOptica, Inc.
  • Paragon Therapeutics, Inc.
  • Parthenon Therapeutics, Inc.
  • Pathalys Pharma, Inc.
  • Pear Bio
  • PepGen Inc.
  • perForm biologics, inc.
  • Permeasis Therapeutics, Inc.
  • Pheon Therapeutics Ltd.
  • Phylaxis Bioscience, LLC
  • PIC Therapeutics, Inc.
  • Pliant Therapeutics, Inc.
  • Potens Animal Health
  • Praeventix, Inc.
  • Prokarium Ltd
  • ProThera Biologics, Inc.
  • Puma Biotechnology, Inc.
  • Q1, Inc.
  • Q2, Inc.
  • QurAlis Corporation
  • Red Arrow Therapeutics, Inc.
  • Rekindle Therapeutics Inc.
  • Relay Therapeutics, Inc.
  • RemeGen Biosciences, Inc.
  • Revalia Bio, Inc.
  • Rhoshan Pharmaceuticals, Inc.
  • Ribo Therapeutics Inc.
  • Right Brain Bio, Inc.
  • Rila Therapeutics, Inc.
  • RocketVax AG
  • Sage Therapeutics, Inc.
  • Sail Biomedicines, Inc.
  • SalioGen Therapeutics, Inc.
  • Scorpion Therapeutics, Inc.
  • Seal Rock Therapeutics, Inc.
  • Seismic Therapeutic, Inc.
  • Senda Biosciences, Inc.
  • Severin Therapeutics, Inc.
  • Sieben Therapeutics, Inc.
  • Sionna Therapeutics, Inc.
  • SLAP Pharmaceuticals, LLC
  • Solu Therapeutics, Inc.
  • SonALAsense, Inc.
  • Sonoma Biotherapeutics, Inc.
  • SOTIO Biotech Inc.
  • Souffle Therapeutics
  • Spyre Therapeutics, Inc.
  • Stoke Therapeutics, Inc.
  • STORM Therapeutics Ltd.
  • Strand Therapeutics, Inc.
  • Sudo Biosciences Inc.
  • Sudo Biosciences Limited
  • Summation Bio, Inc.
  • SURGE Therapeutics, Inc.
  • Syndax Pharmaceuticals, Inc.
  • Synedgen, Inc.
  • Synthego Corporation
  • Tasca Therapeutics Corp.
  • Tavanta Therapeutics, Inc.
  • Tectonic Therapeutic, Inc.
  • Tessera Therapeutics, Inc.
  • Theaprin Pharmaceuticals, Inc.
  • Theragnostics Ltd.
  • Thymmune Therapeutics, Inc.
  • TMS Co., Ltd.
  • TransformaTX Biotherapeutics LLC
  • Treadwell Therapeutics, Inc.
  • TScan Therapeutics, Inc.
  • Vernal Biosciences, Inc.
  • Verra Therapeutics, LLC
  • Versatope Therapeutics, Inc.
  • Verseau Therapeutics, Inc.
  • Verve Therapeutics, Inc.
  • Vicore Pharma AB
  • Vigil Neuroscience, Inc.
  • Viridian Therapeutics, Inc.
  • Viridian, LLC
  • viTToria bioTherapeutics, Inc.
  • Volastra Therapeutics, Inc.
  • Volstra Therapeutics
  • Voyager Therapeutics, Inc.
  • Xbiome, Inc.
  • XenImmune Therapeutics, Inc.
  • YZ Advanced CGT Consulting, LLC
  • Zenas BioPharma
  • Zenon Biotech, Inc.
Learn more about our work in this industry

  • Artha Networks, Inc.
  • Clisertec Corporation
  • Curated Planet, LLC
  • Gleason Technology, Inc.
  • GlobalSign, Inc.
  • GOLDPoint Healthcare, LLC
  • iCapture
  • IQ Proteomics, LLC
  • Liteboxer Technologies, Inc.
  • Micropsi Industries, GmbH
  • Muzooka, Inc.
  • Optera Life Sciences, LLC
  • Parking Edge LLC
  • YBRP, Inc.
Learn more about our work in this industry

  • 4D Molecular Therapeutics, Inc.
  • 5AM Venture Management LLC
  • AllerFund Ventures, LLC
  • ARCH Ventures
  • Columbus Venture Partners, SGEIC, SAU
  • CoVenture
  • Flagship Pioneering
  • GG1978 SICAF SIF
  • GV (Google Ventures)
  • ShangPharma Innovation, Inc.
  • Versant Ventures Management, LLC
  • Westlake BioPartners, LLC
Learn more about our work in this industry

Recent transactions

Previous Page
Next Page
NextPoint Therapeutics, Inc. Logo

NextPoint Therapeutics, Inc.

Series B Financing - $80 million

NextPoint Therapeutics raises $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi.  Additional new investors in the round include Invus, Catalio Capital Management, Sixty Degree Capital and PagodaTree Partners. Existing investors that took part in the financing include MPM Capital Management and Dana-Farber Cancer Institute

Paragon Therapeutics, Inc. Logo

Paragon Therapeutics, Inc. + Apogee Therapeutics, Inc.

Antibody Discovery and Option Agreement

Option for exclusive development and commercial rights to a suite of Paragon’s top-tier antibodies specifically engineered to target some of the largest and highest unmet needs in inflammatory and immunological conditions

Press Release
6 Dimensions Capital Logo

6 Dimensions Capital

VC Investments

Equity investments in multiple portfolio companies, including Hibercell

Puma Biotechnology, Inc. Logo

Puma Biotechnology, Inc.

Clinical Trial

CRO and Site Agreements for an Open-Label, Phase 2 Study with 30 Sites in 9 Countries exploring the efficiency of Neratinib on Patients with Solid Tumors with Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations Or EGFR Gene Amplification

See Study
Epalex Corporation Logo

Epalex Corporation

Series A-3 Financing

Series A-3 preferred equity financing to continue advancing Epalex’s two clinical-stage development programs

Praeventix, Inc. Logo

Praeventix, Inc.

Private Investment

Private Investment from Tellus BioVentures

Vertex Pharmaceuticals Incorporated Logo

Vertex Pharmaceuticals Incorporated

Acquisition of Private Company

Co-counsel to Vertex on acquisition of ViaCyte, a privately-held biotechnology company that received substantial research funding from the California Institute of Regenerative Medicine

Press Release
Versant Ventures Management, LLC Logo

Versant Ventures Management, LLC

Antibody Discovery and Collaboration Agreement

Multi-year collaboration with AbCellera to discover therapeutic antibodies for multiple targets selected by Versant’s portfolio of biologics-focused biotechnology companies

Press Release
Vizgen, Inc. Logo

Vizgen, Inc.

Series C Financing

Vizgen raises Series C equity funding led by Blue Water Life Science Advisors, LLC, ARCH Venture Fund X, L.P. and other existing investors

Press Release
Vernal Biosciences, Inc. Logo

Vernal Biosciences, Inc.

Series A Financing

Vernal Biosciences raises $21M Series A equity funding led by Dynamk Life Sciences Fund, L.P., Charles River Laboratories, Inc. and Ampersand 2020 Limited Partnership

Press Release
Artax Biopharma, Inc. Logo

Artax Biopharma, Inc. + Advent Life Sciences Fund II LP

Series B Financing (Series B4)

Artax Biopharma raises Series B-4 round of equity funding led by Advent Life Sciences Fund II LP, Advent Life Sciences LLP, Columbus Life Science Fund II, FCR, Hiyuli Ventures Limited, Belinda A. Termeer, and other existing investors, plus new investors including Sound Bioventures Fund I AB and and Eli Lilly

Press Release
Dianthus Therapeutics OpCo, Inc. Logo

Dianthus Therapeutics OpCo, Inc.

Series A Financing

Dianthus raises $100 million Series A financing led by 5AM Ventures, Fidelity Management & Research Company, Avidity Partners, Venrock, Fairmount Funds, Tellus BioVentures and other investors

Press Release
This site uses cookies. Some provide anonymous analysis of how our website is used and some are essential to make the website work. Other cookies enable personalized services or social media features to be used. By using our website, you agree to the use of cookies. To find out more, please see our Privacy Policy. You can disable cookies at any time by changing your browser settings.